See what’s clicking on Foxbusiness.com.
Pfizer said Friday it was voluntarily recalling five batches of its Accupril blood pressure pills after finding elevated levels of a potentially carcinogenic agent in the drug.
The drugmaker said it was not aware of any reports of adverse events related to the recalled lots distributed in the United States and Puerto Rico from December 2019 through April 2022.
J&J ISSUES COVID VACCINE SALES FORECAST, CUTS EARNINGS VIEW
Pfizer Canada also recalled all three-dose Accupril lots on Thursday after finding the same contaminant to be above acceptable levels.
Pfizer said there was no immediate risk to patients taking this drug, in which the active ingredient, a nitrosamine, was found.
Exterior view of a Pfizer building in Berlin. (Ulrich Baumgarten via Getty Images/Getty Images)
Nitrosamines are commonly found in water and food, but exposure above acceptable levels for prolonged periods can increase cancer risk.
CLICK HERE TO READ MORE ABOUT FOX BUSINESS
Pfizer also last month recalled some batches of another blood pressure drug, Accuretic, and two authorized cheaper versions due to the presence of the possible carcinogen.